partnering360 is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Industry pundit Joe Hage on medtech innovation in 2017


Joe Hage, a medical device marketing consultant, is well known in medtech circles. In particular, he runs one of the largest and possibly most successful LinkedIn groups, the “Medical Devices Group,” as well as organizing The 10x Medical Device Conference. Insight had a chance to speak with Hage about the state of the industry and his upcoming participation in Medtech Showcase, a two-day forum for companies to share breakthrough medical technologies with an audience of investors and potential commercial partners taking place in January.

Insight: Tell us about yourself and the evolution and success of the Medical Devices Group. It almost seems to have a cult-like following. (more…)

Share Button
BIO-Europe® 2016 recap from day one


It was the best of times, it was the worst of times. This was the biotech industry in 2016.

While this year marked yet another blockbuster year for dealmaking where larger pharma companies scooped up assets from early-stage companies, listed companies struggled through the steepest downturn this century in the biotech stock indexyes, unbelievably, even worse than the equity crash in 2008/9. (more…)

Share Button
Steps for choosing the right development partner


Guest post by Laura Marquis, Vice President and Global Head, Emerging Biopharma, QuintilesIMS™

As I prepare for BIO-Europe® in Cologne, I’m excited by the tremendous opportunities for emerging biopharma companies to deliver much-needed new drugs to patients. These firms are lean, agile and typically led by forward-thinking entrepreneurs with the ambition to change the status quo to develop medicines that otherwise might not make it to market. While this combination of business creativity and innovative applications of biotechnology can certainly lead to success, few emerging biopharma companies have the breadth and depth of experience, infrastructure and expertise needed to execute a complete development and commercialization strategy on their own. But if they partner with an experienced strategic provider, they can reduce risk and gain access to the requisite tools and expertise to help deliver that innovative new drug to market. (more…)

Share Button
A snapshot of hot biotech in Latin America

Biolatam 2016

According to a report from Deloitte, healthcare spending in Latin America is projected to increase 4.6 percent on average annually between 2014 and 2018, as pharmaceutical spending grows an average of 6.1 percent annually. Latin America has an emerging life science market and therefore holds many opportunities for internationally minded organizations. For a preview of Latin America biotech companies you will meet at Biolatam™ life science partnering event in Puerto Rico this November 29–30, read this post by


Share Button
Aging R&D takes center stage at BIO-Europe®


Guest post by John Carroll, Co-Founder and Editor of Endpoints


Last spring I was fascinated to read a story about seniors lobbying to get into a study that was being created to examine the impact metformin has on aging. One of the biotech execs I know has been taking metformin in a kind of n=1 study of his own. And in a recent Forbes interview, Arch Venture Partners’ Robert Nelsen included the generic diabetes drug in his own personal recipe of drugs, vitamins and supplements aimed at spurring a longer, better life.


Nelsen doesn’t just pursue this as his own personal passion, he also invests the VC’s money in the field, backing Unity Biotech, which is at the very beginning stages of developing therapies that can safely sweep away aging, or senescent, cells that start to clutter the body. (No easy task.) (more…)

Share Button
A glimpse into Pharma’s partnering world

Guest post by Doro Shin, Thought Leadership Manager at Informa Pharma Intelligence


Fortune Magazine once stated, “Alliances have become an integral part of contemporary strategic thinking,” and the pharma industry is no stranger to this concept. In fact, an upcoming whitepaper to be released at next month’s BIO-Europe® in Cologne, Germany, did find that the current state of drug development is indeed a collaborative endeavor, and the majority of companies, both public and private, possess partnered products within their pipelines. Within the remainder of the report, Partnering in the Pharma world: BIO-Europe® and Industry trends 20122015, Pharma Intelligence delves into the world of collaboration within the industry to gain insight into this oft-used strategy, overall and within the ever popular oncology space. (more…)

Share Button
EBD Group’s partnering community reaches 36,000+ members


Organic partnerships, dealmaking and licensing opportunities are hard won in this industry. The sheer time and resources it takes to build relationships and formulate quality business deals can be an exhaustive process.


That’s where EBD Group’s digital partnering applications have bridged the gap.



The Early Days

What started out nearly two decades ago as a system to facilitate networking opportunities at specific EBD Group industry conferences, has now become a robust, 24/7 world-class online solution with more than 36,000 engaged online members actively seeking to form quality relationships and deals within the industry.   (more…)

Share Button
Are your business development skills getting you the results you want?

The BIO Advanced Business Development course

Companies value executives who can think on their feet, and not only conceive of winning strategies, but execute on those strategies, according to a recent Harvard Business Review article.


Business development professionals are busy people. For one, there are all those relationships to keep up. It’s hard to find time to hone essential skills that can close a deal. And while some might say that business development is a function of sales, others would say it is a marketing function. Ultimately, the customer is the endgame for both, and the best BD executives use a blended approach. The Forbes article “What, Exactly, Is Business Development?” defines BD as “the creation of long-term value for an organization from customers, markets, and relationships.” No matter how you define it, it’s the strategy that gets you there. (more…)

Share Button
Protecting your IP: Checklist

In biotechnology you cannot get very far without solid IP. For a startup company, having a solid IP strategy is an essential requirement to maximizing value. Muna Abu-Shaar, PhD, Founder of Biospark Intellectual Property Law, presented core elements to protecting IP during Biotech Startup Day in Boston. Here is what we learned: (more…)

Share Button
Top tips from investors on pitching your company from BioPharm America™ 2016


A group of seasoned biotech investors gathered this week at BioPharm America™ to meet with innovative biotech companies, and to participate in “The Perfect Pitch: Do you have what it takes to win over investors?” as pitch judges. The session gave participants the opportunity to give a 30-second elevator pitch to win a one-to-one meeting with a leading life science private equity investor.


Doug MacDougall of MacDougall Biomedical Communications moderated the session, and seven investor judges sat on the panel, including: Sinclair Dunlop of Epidarex Capital; Carolyn Green of Pfizer Worldwide R&D, ERDI; Sam Hall of Appletree Partners; Rick Jones of Broadview Ventures; Dennis J. Purcell of Aisling Capital; Jeremy Springhorn of Flagship Ventures; and David Steinberg of PureTech.


Michael Winlo and Simon Scott of Linear Clinical Research Limited

The winner of the competition was Michael Winlo, CEO of Linear Clinical Research Limited who pitched on his Perth, Australia-based dedicated early phase clinical trials facility.


But Winlo is not the only winner, since the best tips from the investors are provided here for you, below: (more…)

Share Button